Coupang, Inc. (CPNG)

Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,796	5,879	5,243	3,509	3,488	1,251
Short-Term Investments	-	-	-	-	-	18.38
Cash & Short-Term Investments	6,796	5,879	5,243	3,509	3,488	1,270
Cash Growth	22.76%	12.13%	49.42%	0.61%	174.66%	3.89%
Receivables	499	407	314	184	175.35	71.26
Inventory	2,285	2,099	1,666	1,657	1,422	1,161
Prepaid Expenses	503	458	316	304	232.45	-
Restricted Cash	93	151	353	176	319.8	144.95
Other Current Assets	-	-	-	-	-	193.47
Total Current Assets	10,176	8,994	7,892	5,830	5,637	2,841
Property, Plant & Equipment	5,964	4,829	4,066	3,225	2,722	2,029
Goodwill	-	-	-	-	-	4.25
Other Intangible Assets	210	271	37	-	-	-
Long-Term Deferred Tax Assets	646	622	925	40	-	-
Other Long-Term Assets	835	628	426	418	282.87	193.17
Total Assets	17,831	15,344	13,346	9,513	8,642	5,067
Accounts Payable	6,487	5,554	5,099	3,622	3,443	2,908
Accrued Expenses	430	461	352	299	304.29	115.61
Short-Term Debt	785	479	282	175	7.81	156.68
Current Portion of Long-Term Debt	169	66	203	129	341.72	67.58
Current Portion of Leases	505	422	386	326	287.07	207.2
Current Unearned Revenue	188	141	97	92	93.97	65.26
Other Current Liabilities	805	593	526	420	266.71	212.48
Total Current Liabilities	9,369	7,716	6,945	5,063	4,744	3,733
Long-Term Debt	850	988	529	538	283.19	943.19
Long-Term Leases	2,270	1,770	1,387	1,234	1,201	859.48
Other Long-Term Liabilities	657	693	381	264	237.12	135.2
Total Liabilities	13,146	11,167	9,242	7,099	6,466	5,671
Common Stock	-	-	-	-	0.18	45.12
Additional Paid-In Capital	9,025	8,736	8,489	8,154	7,874	25.04
Retained Earnings	-4,090	-4,229	-4,383	-5,743	-5,651	-4,108
Comprehensive Income & Other	-250	-404	-17	3	-47.74	-31.09
Total Common Equity	4,685	4,103	4,089	2,414	2,176	-4,069
Minority Interest	-	74	15	-	-	-
Shareholders' Equity	4,685	4,177	4,104	2,414	2,176	-603.25
Total Liabilities & Equity	17,831	15,344	13,346	9,513	8,642	5,067
Total Debt	4,579	3,725	2,787	2,402	2,121	2,234
Net Cash (Debt)	2,217	2,154	2,456	1,107	1,367	-964.28
Net Cash Growth	21.75%	-12.30%	121.86%	-19.00%	-	-
Net Cash Per Share	1.20	1.18	1.36	0.63	0.96	-33.24
Filing Date Shares Outstanding	1,823	1,805	1,793	1,774	1,756	105.82
Total Common Shares Outstanding	1,819	1,801	1,790	1,773	1,754	105.82
Working Capital	807	1,278	947	767	892.52	-892
Book Value Per Share	2.58	2.28	2.28	1.36	1.24	-38.45
Tangible Book Value	4,475	3,832	4,052	2,414	2,176	-4,073
Tangible Book Value Per Share	2.46	2.13	2.26	1.36	1.24	-38.49
Land	-	401	323	296	140.79	142.4
Buildings	-	794	751	302	320.06	181.53
Machinery	-	1,201	993	782	719.89	638.85
Construction In Progress	-	377	347	428	200.74	169.79
Leasehold Improvements	-	929	662	525	340.47	172.86

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q